Drug resistance, poor bioavailability, and systemic toxicity remain central challenges in modern therapeutics. Nanopharmaceuticals address these by enabling:
- Targeted delivery: Directing drugs to specific tissues or cell types
- Enhanced bioavailability: Improving absorption and controlled release
- Interdisciplinary innovation: Combining materials science, biology, and pharmacology
These technologies are increasingly critical in oncology, gene therapy, and personalized medicine, offering tangible improvements over conventional drug delivery methods.
- Introduction to bio-nanopharmaceuticals and their therapeutic significance
- Principles of nanotechnology in drug design and delivery
- Nanocarrier types: liposomes, dendrimers, micelles, and solid lipid nanoparticles
- Drug encapsulation and targeted release mechanisms
- Overcoming drug resistance and improving half-life with nanocarriers
- Case studies in cancer therapy using nanoparticle-based drugs
- Nanoparticles as vectors for DNA, RNA, and CRISPR therapeutics
- Design strategies for patient-specific drug delivery
- Evaluating efficiency, targeting, and immunogenicity of gene therapies
- Scaling up nanopharmaceutical production and maintaining GMP standards
- Regulatory frameworks and ethical considerations (FDA, EMA)
- Emerging trends: smart nanoparticles, multifunctional carriers, precision medicine applications
Lab simulations for drug encapsulation and release
Analytical platforms (DLS, TEM, HPLC)
Computational frameworks for pharmacokinetics
Case study evaluation methods
- Cancer therapy: Nanocarriers targeting tumor cells, reducing side effects
- Gene therapy: Delivery of nucleic acids with high specificity
- Personalized medicine: Tailoring treatments based on patient biomarkers
- Industrial drug development: Scaling nanopharmaceuticals for clinical use
- Regulatory science: Evaluating safety, efficacy, and compliance for new therapies
- Postgraduate and PhD researchers in nanotechnology, pharmaceutical sciences, or biomedical engineering
- Pharmaceutical industry professionals involved in R&D or drug formulation
- Biotechnology specialists exploring nanomedicine
- Materials scientists and engineers interested in therapeutic applications
Prerequisites or Recommended Background: Basic knowledge of pharmaceutical sciences or molecular biology. Introductory familiarity with nanomaterials and lab methods. No advanced coding required; conceptual understanding of drug delivery preferred.
Unlike generic nanotechnology courses, this program:
- Integrates theory with practical lab and computational work
- Focuses on translational applications in oncology, gene therapy, and personalized medicine
- Provides exposure to regulatory, ethical, and manufacturing contexts
- Emphasizes design, evaluation, and applied problem-solving over abstract theory








Reviews
There are no reviews yet.